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The protein-based molecular recognition of the adenine ring is essential to understand protein function and drug design as well. In 
this paper, a variety of the adenine-based inhibitors with modified groups of amino groups, nitrogen and oxygen atoms in the ar-
omatic ring are designed, and the binding capability of these adenosine analogues with an aminoglycoside antibiotic kinase 
[APH(3′)-IIIa] are investigated with activity assays and isothermal titration calorimetry (ITC) experiments. 1-aminoisoquinoline is 
one of the weakest substrates bound to APH(3′)-IIIa with the lowest affinity (high ki and high kd) and the smallest negative value 
of free energy change (G) among the inhibitors tested. The binding process of adenine and 5-nitroisoquinoline to APH(3′)-IIIa is 
an enthalpy-driven event with unfavorable entropy, which is consistent with the energy change induced by the binding of ATP to 
the enzyme. However, the reverse is true for 1-aminoisoquinoline, 3-amino-5-nitrobenzisothiazole, 5-aminoisoquinoline binding 
to the enzyme because the entropy is more favorable and the enthalpy makes a lower contribution to the binding process. These 
results suggest that small changes of the adenine ring can lead to significant influence on the ability of these analogues to occupy 
the adenine-binding region of the enzyme, which can be the potential inhibitors as drug candidates against the bacterial resistance. 
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As a multifunctional nucleotide, adenosine 5′-triphosphate 
(ATP) plays critical roles across all forms of life. It is pro-
duced as an energy source to participate in the processes of 
cell signaling and protein synthesis [1–3]. In signal trans-
duction pathways, molecular recognition of ATP with pro-
teins has emerged as a subject of great interest. Recent 
studies on the protein kinase have demonstrated that most of 
the non-covalent interactions involved in the binding be-
tween proteins and the adenine ring are hydrogen-bonding, 
- stacking, and cation- interactions [3–7]. The investiga-
tions on these specific non-covalent intermolecular interac-
tions between protein and adenine are important in under-
standing the acting of protein functions and the design of 
new drugs. One of the enzymes which typifies the majority 
of these structural motifs is aminoglycoside 3′-phosphotrans-     
ferase (APH(3′)-IIIa), a well-studied aminoglycoside phos-
photransferase which is important for antibiotic drug re-
sistance.  
APH(3′)-IIIa is very promiscuous in its substrate selec-
tion, being able to phosphorylate the 3′ and 5′-hydroxyl 
functionalities of aminoglycosides dependent on the ATP 
hydrolysis [8–10]. Phosphorylated antibiotic cannot effi-
ciently bind to its target, i.e. the bacterial ribosomal amino-      
acyl-tRNA site of the 16S RNA, which induces the re-
sistance phenotype in organisms harboring the aminoglyco-
side phosphotransferases [11]. On the basis of the catalyzed 
modification reaction, these non-covalent interactions are 
critical for the recognition and modification of various anti-
biotics, i.e. the binding of nucleotides. Schematic of these 
non-specific interactions between APH(3′)-IIIa and nucleo-
tide ligands based on the crystal structure of the complex is 
shown in Figure 1. In detail, the interaction of - stacking  
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Figure 1  (Color online) Schematic representation of the non-specific 
interactions between APH(3′)-IIIa and nucleotide ligands based on the 
crystal structure of the complex. 
occurs between aromatic ring of Tyr42 and adenine ring in 
ATP, and two hydrogen bonds locate between the N1 atom 
of the nucleotide and the backbone amide of Ala93, the N6 
atom and the backbone carbonyl oxygen of Ser91, respec-
tively. In addition, the ribose component interacts with the 
protein via a single hydrogen bond between the O3′ oxygen 
of the sugar and the carbonyl oxygen of Ser194 [12–14]. 
Thus, the nitrogen and oxygen atoms in the adenine ring are 
vital for the recognition of the nucleotides with enzymes. It 
is likely that some of the adenine-based inhibitors can be 
designed to reverse the antibiotic resistance by taking ad-
vantage of the binding opportunities available in this deep, 
interaction-rich pocket of APHs. 
In this work, five typical adenosine analogues are well 
designed to investigate the role of each group in adenosine 
ring binding to the aminoglycoside antibiotic kinase (APH(3′)- 
IIIa), probed by activity assays and isothermal titration cal-
orimetry experiments. As shown in Figure 2, these adenine 
analogues are typical structural motifs with different modi-
fied amino groups, nitrogen and oxygen atoms in the aro-
matic ring. The results indicate that the affinity of the 
1-aminoisoquinoline with three nitrogen atoms replaced by 
carbon in the adenine ring to APH(3′)-III is dramatically 
decreased with the lowest affinity (high ki and high kd) and 
the smallest negative G value among the five inhibitors. In 
contrast, the binding capability to APH(3′)-IIIa is obviously 
enhanced for the cases of adenosine analogues 5-nitroiso-    
quinoline and 3-amino-5-nitrobenzisothiazole due to the 
presence of more electronic groups, such as O-N=O. In fact, 
the binding mechanisms of these adenosine analogues to 
enzyme are distinct from each other. Adenine and 5-nitroiso-     
quinoline binding to APH(3′)-III is an enthalpy-driven event 
with unfavorable entropy, which is consistent with the en-
ergy changes with ATP binding to the enzyme. However, 
the bindings of 1-aminoisoquinoline, 3-amino-5-nitroben-     
zisothiazole, and 5-aminoisoquinoline to the enzyme are 
mainly driven by the entropy instead of enthalpy which  
 
Figure 2  (Color online) Electrostatic potential surface of some adenine 
analogues of adenine, 1-aminoisoquinoline, 5-nitroisoquinoline, 3-amino- 
5-nitrobenzisothiazole and 5-aminoisoquinoline. 
contributes very little to the binding. The results reveal that 
small changes in the structure of the adenine ring can lead 
to significant changes in the ability of these analogues to 
occupy the adenine-binding region of the enzyme. It is well 
known that the affinity of ATP as a cofactor to the enzyme 
is mainly determined by the interactions of the adenine ring, 
which is important for the recognition and modification of 
antibiotics with enzymes subsequently. Once cofactors fail 
to occupy the active region of enzymes priorly due to the 
presence of competitive inhibitors, the enzymes will hardly 
capture the antibiotics and modify them. Facing to the in-
creasing resistance of antibiotics from modified enzymes, 
the investigation of these important interactions between 
protein kinase and typical adenosine analogues will shed 
light on drug design of the potential enzyme inhibitors to 
against the bacterial resistance. 
1  Materials and methods 
All adenine analogues were purchased from Sigma-Aldrich 
Co. (St. Louis, MO) with the highest purity commercially 
available, as shown in Figure 2. The enzymes of aminogly-
coside antibiotic kinase were expressed and purified as be-
fore in our laboratory [10,15]. All other chemical reagents 
used in our experiment were of analytical grade without 
further purified. All buffer solutions were prepared with 
Milli-Q super purified water. 
The catalytic activity of APH was determined in a cou-
pled enzyme assay system based on the measurement of the 
decrease in NADH absorbance as described before [10,15]. 
Rate measurements were carried out by monitoring the de-
crease in absorbance at 340 nm on the Cary 50 UV-vis 
spectrophotometer (Varian Instruments, Palo Alto, CA) at 
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room temperature. 
Isothermal titration calorimetry experiments were per-
formed at 25°C using a VP-ITC microcalorimeter from Mi-
crocal, Inc. (Northampton, MA). All measurements were 
carried out in 50 mM Tris-HCl or HEPES buffers with 100 
mM NaCl at pH 7.5, which also contained 10% (v/v) 
DMSO to dissolve the ligands. The enzyme stock was dia-
lyzed extensively against buffer, and ligand solutions were 
prepared in the final dialyzate. Both enzyme and ligand so-
lutions were degassed under vacuum for 15 min at 20°C. 
Titrations consisted of 29 injections of 10 L and were sep-
arated by 360 s. Cell stirring speed was 300 r/min. For each 
titration, the enzyme concentration was 20 M in the sam-
ple cell, and the inhibitor concentration was from 0.3 to 3 
mM in the injection syringe. To obtain reliable dissociation 
constants, the c-value, a parameter obtained by the multi-
plication of the association constant and the total concentra-
tion of ligand binding sites [16], was kept between 10 and 
100 for all titrations. Considering the affinity of 5-nitroiso-      
quinoline with enzyme, the tertiary titration of adenine in-
hibitors into enzyme with tobramycin was repeated at the 
same conditions to accurate determine the competition of 
different ligands. The enzyme activity of APH(3′)-III was 
tested in the presence of osmotic solvent of DMSO, and no 
loss of activity was detected at the DMSO concentration 
less than 20% (v/v). Control runs were performed by titrat-
ing ligands into buffer without enzyme, and the resulting 
reference signal was subtracted from the corresponding ex-
perimental data. 
Thermodynamic parameters n (stoichiometry), kd (disso-
ciation constant), and H (enthalpy change) were obtained 
by nonlinear least-squares fitting of the experimental data 
except 5-aminoisoquinoline using a single-site binding model 
of Origin software package provided by the instrument. The 
free energy of binding (G) and entropy change (S) were 
obtained using 
 ln ,aG RT K    (1) 
 .G H T S      (2) 
The intrinsic enthalpy of binding was determined by the 
simultaneous solutions of  
 abs1 int ion1 ,H H H n       (3) 
 abs2 int ion2 .     H H H n  (4) 
Here, the subscripts “1” and “2” refer to different buffers; 
Habs is the observed enthalpy change upon binding; Hion is 
the heat of ionization of the buffer; and n is the net uptake 
of protons by the buffer upon complex formation [17,18]. 
The heat of ionization for HEPES is +21.01 kJ/mol (4.87 
kcal/mol) and that for Tris-HCl is +49.75 kJ/mol (11.7 
kcal/mol) [19]. 
2  Results 
The thermodynamic properties for the binding between 
APH(3′)-IIIa and several adenine inhibitors were studied by 
ITC. In detail, thermodynamic data for the formation of the 
binary enzyme-inhibitor complexes are present in Table 1 
and Figure 3. It is shown that the binding constants and 
thermodynamic parameters are clearly different although 
these adenosine analogues have similar structures, processed 
with the adenine ring and similar size.  
In the case of 1-aminoisoquinoline, three nitrogen atoms 
with negative and positive charge densities in adenine are 
substituted by carbon in the adenine ring. Although the in-
hibition constant is close to that of adenine, the association 
constant is decreased by ~5 fold. This result indicates that 
the electrostatic potential from these nitrogen atoms in the 
adenine ring prefers the binding interactions of enzyme with 
analogues. However, for 5-aminoisoquinoline, in which the  
Table 1  Thermodynamics parameters for adenine inhibitor binding to APH(3′)-III at pH 7.5a) 




13.6 6.98 +0.37 6.61 0.001 




74.6 0.755 4.85 5.61 
0.002 




2.85 8.62 +1.08 7.54 
1.007 




3.85 5.88 1.48 7.36 0.635 




1.13 0.44 7.64 8.08 
0.011 
HEPES 1.43 0.52 7.42 7.94 
ATP*   11.0 17.5 +10.6 6.88  
a) Fitting errors: kd <12%, H<10%, n<0.1%. *, The value of ATP binding to APH(3′)-IIIa were in 50 mM HEPES-NaOH at pH 7.5, 40 mM KCl, and 
10 mM MgCl2 using ITC at 303 K as described in [5]. 
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Figure 3  ITC profiles of adenine titration into APH(3′)-III in Tris-HCl 
buffer. 
N1 atom is just moved to N5 position of 1-aminoisoquino-     
line, the association constant is increased by ~80 fold alt-
hough the inhibition constant is only decreased by one-fold. 
The significant change of affinity constant indicates that the 
positive electron potential in N5 position is important for 
the binding of adenine to enzyme. With regard to other two 
adenosine analogues, i.e. 5-nitroisoquinoline and 3-amino- 
5-nitrobenzisothiazole, they have the similar structures ex-
cept an additional sulfur atom and an amino group in 3- 
amino-5-nitrobenzisothiazole. They are the effective inhib-
itors (lower ki) with higher affinity to APH(3′)-IIIa. It is 
found that the dissociation constant in ITC experiments is 
well correlated to the inhibition constants observed in ki-
netic assay; for example, the values of kd decrease with the 
decreasing ki. In fact, there is an exception for the case of 
5-aminoisoquinoline with a larger value of ki but a smaller 
value of kd, which may be caused by the positive electron 
potential in the N5 position of adenien ring. The affinity 
analyses from the adenine ring with different groups reveal 
that minor modifications on the adenine ring can lead to a 
significant change in the binding capability to enzymes.  
In fact, such an effect can also be derived from the 
change of their thermodynamic properties. The binding 
process of adenine analogues to APH(3′)-IIIa exhibits large 
exothermic heat associating with negative change of free 
energy G values. The window of negative ∆G values is as 
narrow as 2.58 kcal/mol (from 5.50 to 8.08 kcal/mol). In 
addition, the change of enthalpy ∆H values varies from 0.44 
to 15.5 kcal/mol, and the contribution of entropy to the free 
energy (TS) varies from 7.64 to 8.52 kcal/mol. The re-
sults show that 1-aminoisoquinoline is one of the weakest 
substrates binding to APH(3′)-IIIa with the lowest value of 
affinity (high ki and kd) and the smallest change of negative 
G value among the five inhibitors tested in this work. As 
shown in Table 1 and Figure 4, the binding process of ade-
nine and 5-nitroisoquinoline to APH(3′)-IIIa is an enthalpy- 
driven event with unfavorable entropy, which consists well 
with the energy changes in the binding process between 
ATP and the enzyme [15]. However, for the case of 1- 
aminoisoquinoline, 3-amino-5-nitrobenzisothiazole, and 5- 
aminoisoquinoline, it is quite different that the entropy is 
more favorable and the contribution of enthalpy is extremely 
small.  
Additionally, the tertiary titrations of some adenine ana-
logues with high affinity to APH(3′)-IIIa were also per-
formed in the presence of tobromycin. For 5-nitroisoquino-     
line, the association constants and the enthalpic contribution 
do not change too much (less than 30%), but the disfavora-
ble entropic contribution is decreased by 1–2 folds in the 
presence of antibiotics. For the case of 3-amino-5-nitro-     
benzisothiazole, the accurate free energy changes can be 
hardly measured in the presence of tobramycin due to the 
extremely low association constant. Tobramycin is a com-
petitive inhibitor of APH(3′)-IIIa, which lacks the 3′-hy-    
droxyl group of kanamycin B and cannot be modified by the 
enzyme [18]. The binding of tobramycin to APH(3′)-IIIa is 
much tighter than these adenine analogues (kd=0.8 M). 
Thus, the favorable enthalpy compensates the entropic pen-
alty yielding more negative G values. The large effect of 
tobramycin on the binding process of adenine inhibitor to 
enzymes indicates that some active sites for antibiotics on 
enzyme may be occupied or changed in the association of 
enzyme and adenine analogues. 
As shown in Table 1, all titrations are performed in two 
different buffers with different heat of ionization (Tris, 11.7 
kcal/mol vs. HEPES, 4.87 kcal/mol) to determine protona-
tion/deprotonation of functional groups involved in the 
binding interaction. This observation shows that n values 
are zero during the formation of APH(3′)-IIIa with adenine, 
1-aminoisoquinoline and 5-aminoisoquinoline although these 
analogues are with the NH2 groups on the adenine ring. 
This may be a proper balance between the electrostatic den-
sity on the aromatic system and the additional protonation/ 
deprotonation accompanied in the enzyme side chains. For 
5-nitroisoquinoline and 3-amino-5-nitrobenzisothiazole, the 
observed n values are 1.007 and 0.635, respectively. If 
nitrogen atom and O-N=O group in adenine ring are re-
sponsible for the protonation of 5-nitroisoquinoline, addi-
tional fraction of NH2 group and sulfur atom in 3-amino-  
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Figure 4  The changes of the free energy (G), enthalpy (H) and entropy (TS) of different adenine analogues binding to APH(3′)-III in Tris-HCl (a) 
and HEPES buffers (b). 
5-nitrobenzisothiazole will be responsible for deprotonation 
of some groups in the complexes. Similarly, the contribu-
tion from the ionization of enzyme side chain to the ob-
served heat change of the complex formation cannot be ex-
cluded although it is different in the presence of adenine 
analogues. Note that the interpretation of changes in en-
thalpy and entropy due to the modification on the adenine 
ligands may be complicated. The contribution of solvent, 
the compensation of enthalpy and entropy, and the effects of 
cooperative hydrogen bonding are all critical to the binding 
process. However, the change of the free energy due to a 
single substituent on the adenine inhibitors reveals the mo-
lecular determinants of affinity and specificity for nucleo-
tide ligands binding to APH(3′)-IIIa.  
3  Discussion 
As mentioned above, the binding of ATP to APH(3′)-IIIa is 
enthalpically driven and exhibits a strongly disfavored en-
tropic contribution. The negative H values are associated 
with the favorable binding contacts, such as polar interac-
tions, electrostatic forces, van der Waals forces, and hydro-
gen bonds between the adenine ring and active sites of 
APH(3′)-IIIa [12–14]. As shown in Figure 1, these interac-
tions consist of the - stacking with aromatic ring of Tyr42, 
the hydrogen bonds between the nucleotide and the back-
bone amide of Ala93 and one between the N6 atom and the 
backbone carbonyl oxygen of Ser91. Additionally, the ri-
bose component interacts with the protein via a single hy-
drogen bond between the O3′ oxygen of the sugar and the 
carbonyl oxygen of Ser194 [18–20]. So these amino groups, 
nitrogen and oxygen atoms in the aromatic ring are im-
portant for the recognition of the nucleotides with enzymes. 
The addition and substitution of some groups in the adenine 
analogues can disrupt the contacts between them, and lead 
to the associated energy changes. As shown in Table 1, the 
enthalpic and entropic contributions are quite different alt-
hough the free energies of adenine and 5-nitroisoquinoline 
binding to APH(3′)-III are close to that of ATP with en-
zymes. In contrast to the case of ATP, the favorable enthal-
py and disfavorable entropy both decreased during the for-
mation of enzyme and adenine analogues, and thus the final 
energy does not change too much. The structure of adenine 
is close to ATP with N1 atom and NH2 in N6 of adenine 
ring. However, 5-nitroisoquinoline without amino group 
behaves more enthalpically. This may be responsible to the 
N1 and O-N=O group in adenine ring. Especially the 
O-N=O group contributes to the proton transfer during the 
interactions. The enthalpical contributions are less favorable 
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and the entropical contributions become more favorable for 
the binding of 1-aminoisoquinoline, 3-amino-5-nitroben-    
zisothiazole, 5-aminoisoquinoline with the enzyme. These 
results suggest that the electrostatic interactions are dimin-
ished and the increased hydrophobic interactions between 
enzyme and ligands play a prominent role in these cases. 
However, it is somewhat exceptional for 3-amino-5-nitro-       
benzisothiazole with more electronic groups, such as NH2, 
O-N=O groups and nitrogen and sulfur atoms. Probably, the 
aromatic stacking interactions between APH(3′)-IIIa and 
adenine ring can supply to most of the total nucleotide- 
binding energy [19–21]. Certainly the minor change in the 
structure of the enzyme and adenine ring can not only lead to 
the disruption of a single contact but also influence the nature 
of remaining contact. And the ability of the enzyme to in-
teract with the modified nucleobases will be attributed to the 
global changes in the thermodynamic parameters.  
Overall, considering the importance of ATP as a cofactor 
of the enzymatic modification on the drug of antibiotics, 
several adenine analogues are constructed and characterized 
with the model system of APH(3′)-IIIa [1–3,8–10]. The 
studies permit us to determine individual contribution of 
selected amino groups, nitrogen and oxygen atoms in the 
aromatic ring of the ligands to the global thermodynamic 
properties of the enzyme-ligand complex. Results described 
in this paper show that the recognition of APH with adenine 
analogues involves a complex pattern associated with the 
favorable binding contacts, and protonation and deprotona-
tion between the adenine ring and active sites of APH(3′)- 
IIIa under the given experiment conditions. These findings 
highlight that small changes in the structure of the adenine 
ring can lead to significant changes in the ability of these 
analogues to occupy the adenine-binding region of the en-
zyme. Because of the prevalence of the unique aminoglyco-
side modifying enzymes, our work based on the molecular 
recognition of enzymes with adenine analogues provides a 
useful way for the design of enzyme inhibitors that have the 
potential to reverse aminoglycoside antibiotic. 
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